• 1
    Meinhardt PL, Casemore DP, Miller KB. Epidemiological aspects of human cryptosporidiosis and the role of waterborne transmission. Epidemiol Rev 1996; 18: 118136.
  • 2
    Hunter PR, Nichols G. The epidemiology and clinical features of cryptosporidium infection in immune-compromised patients. Clin Microbiol Rev 2002; 15: 145154.
  • 3
    Hunter PR, Hughes S, Woodhouse S et al. Health sequelae of human cryptosporidiosis in immunocompetent patients. Clin Infect Dis 2004; 39: 504510.
  • 4
    Smith HV, Rose JB. Waterborne cryptosporidiosis: current status. Parasitol Today 1998; 14: 1422.
  • 5
    Naumova EN, Christodouleas J, Hunter PR, Syed Q. Temporal and spatial variability in cryptosporidiosis recorded by the surveillance system in North West England in 1990–1999. J Water Hlth 2005; 3: 185196.
  • 6
    Frost FJ, De La Cruz AA, Moss DM, Curry M, Calderon RL. Comparisons of ELISA and Western blot assays for detection of Cryptosporidium antibody. Epidemiol Infect 1998; 121: 205211.
  • 7
    Frost FJ, Muller T, Craun GF, Lockwood WB, Calderon RL. Serological evidence of endemic waterborne Cryptosporidium infections. Ann Epidemiol 2002; 12: 222227.
  • 8
    Moss DM, Bennett SN, Arrowoods MJ, Wahlquist SP, Lammie PJ. Enzyme-linked immunoelectronictransfer blot analysis of a cryptosporidiosis outbreak on a United States coast guard cutter. Am J Trop Med Hyg 1998; 58: 110118.
  • 9
    Moss DM, Chappel CL, Okhuysen PC et al. The antibody response to 27–17- and 15-kDa Cryptosporidium antigens following experimental infection in humans. J Infect Dis 1998; 178: 827833.
  • 10
    Frost FJ, Calderon RL, Muller TB et al. A two-year follow-up survey of antibody to Cryptosporidium in Jackson County, Oregon following an outbreak of waterborne disease. Epidemiol Infect 1998; 121: 213217.
  • 11
    Arrowood MJ, Sterling CR. Isolation of Cryptosporidium oocysts and sporozoites using discontinuous sucrose and isopycnic percoll gradients. J Parasitol 1987; 73: 314319.
  • 12
    Moss DM, Lammie PJ. Proliferative responsiveness of lymphocytes from Cryptosporidium parvum-exposed mice to two separate antigen fractions from oocysts. Am J Trop Med Hyg 1993; 49: 393.
  • 13
    Cama VA, Arrowood MJ, Ortega YR, Xiao L. Molecular characterisation of the Cryptosporidium parvum IOWA isolate kept in different laboratories. J Eukaryot Microbiol 2006; 53: S40S42.
  • 14
    Muller TB, Frost FJ, Craun GF, Calderon RL. Serological responses to Cryptosporidium infection. Infect Immun 2001; 69: 19741975.
  • 15
    Frost FJ, Muller T, Craun GF, Calderon RL, Roefer PA. Paired city Cryptosporidium serosurvey in the southwest USA. Epidemiol Infect 2001; 126: 301307.
  • 16
    Caputo CA, Forbes A, Frost F et al. Determinants of antibodies to Cryptosporidium infection among gay and bisexual men with HIV infection. Epidemiol Infect 1999; 122: 291297.
  • 17
    Frost FJ, Muller T, Craun GF et al. Serological analysis of a cryptosporidiosis epidemic. Int J Epidemiol 2000; 29: 376379.
  • 18
    Frost FJ, Kunde TR, Muller TB et al. Serological responses to Cryptosporidium antigens among users of surface-vs. ground-water sources. Epidemiol Infect 2003; 131: 11311138.
  • 19
    Frost FJ, Muller TB, Fairley CK, Hurley JS, Craun GF, Calderon RL. Serological evaluation of Cryptosporidium oocyst findings in the water supply for Sydney, Australia. Int J Environ Hlth Res 2000; 10: 3540.
  • 20
    Isaac-Renton J, Blatherwick J, Bowie WR et al. Epidemic and endemic seroprevalence of antibodies to Cryptosporidium and Giardia in residents of three communities with different drinking water supplies. Am J Trop Med Hyg 1999; 60: 578583.
  • 21
    Moss DM, Bennett SN, Arrowood MJ et al. Kinetic and isotypic analysis of specific immunoglobulins for crew members with cryptosporidiosis on a US Coast Guard cutter. J Eukaryotic Microbiol 1994; 41: 52s77s.
  • 22
    Chalmers RM, Hughes S, Thomas A, Woodhouse S, Thomas PD, Hunter P. Laboratory ascertainment of Cryptosporidium and local authority policies for investigating sporadic cases of cryptosporidiosis in two regions of the United Kingdom. Comm Dis Pub Hlth 2002; 5: 114118.
  • 23
    Xiao LH, Fayer R, Ryan U, Upton SJ. Cryptosporidium taxonomy: recent advances and implications for public health. Clin Microbiol Rev 2004; 17: 7297.
  • 24
    Priest JW, Bern C, Xiao LH et al. Longitudinal analysis of Cryptosporidium species-specific immunoglobulin G antibody responses in Peruvian children. Clin Vaccine Immunol 2006; 13: 123131.
  • 25
    Chalmers RM, Elwin K, Reilly WJ, Irvine H, Thomas AL, Hunter PR. Cryptosporidium in farmed animals: the detection of a novel isolate in sheep. Int J Parasitol 2002; 32: 2126.
  • 26
    McLauchlin J, Casemore DP, Moran S, Patel S. The epidemiology of cryptosporidiosis: application of experimental sub-typing and antibody detection systems to the investigation of water-borne outbreaks. Folia Parasitol (Praha) 1998; 45: 8392.
  • 27
    Okhuysen PC, Chappell CL, Sterling CR, Jakubowski W, DuPont HL. Susceptibility and serologic response of healthy adults to reinfection with Cryptosporiodium parvum. Infect Immun 1998; 66: 441443.
  • 28
    Frost FJ, Roberts M, Kunde TR et al. How clean must our drinking water be: the importance of protective immunity. J Infect Dis 2005; 191: 809814.
  • 29
    Frost FJ, Tollestrup K, Craun GF, Fairley CK, Sinclair MI, Kunde TR. Protective immunity associated with a strong serological response to a Cryptosporidium-specific antigen group, in HIV-infected individuals. J Infect Dis 2005; 192: 618621.
  • 30
    Hunter PR, Chalmers RM, Syed Q, Hughes LS, Woodhouse S, Swift L. Foot and mouth disease and cryptosporidiosis: possible interaction between two emerging infectious diseases. Emerg Infect Dis 2003; 9: 109112.
  • 31
    Lake IR, Nichols G, Bentham G, Harrison FCD, Hunter PR, Kovats RS. Cryptosporidiosis decline after regulation, England and Wales 1989–2005. Emerg Infect Dis 2007; 13: 623625.